Credit Suisse Group reiterated their neutral rating on shares of Aetna (NYSE:AET) in a research note published on Wednesday. The brokerage currently has a $195.00 price target on the stock, up from their prior price target of $174.00.
AET has been the topic of several other research reports. Argus restated a buy rating and set a $185.00 target price (up previously from $165.00) on shares of Aetna in a research note on Tuesday, September 12th. Zacks Investment Research upgraded shares of Aetna from a hold rating to a buy rating and set a $174.00 target price on the stock in a research note on Thursday, October 12th. Citigroup upped their target price on shares of Aetna from $183.00 to $197.00 and gave the company a buy rating in a research note on Thursday, November 2nd. Jefferies Group upped their target price on shares of Aetna from $163.00 to $165.00 and gave the company a hold rating in a research note on Friday, October 13th. Finally, Piper Jaffray Companies restated a hold rating and set a $187.00 target price on shares of Aetna in a research note on Friday, November 3rd. Twelve equities research analysts have rated the stock with a hold rating and fourteen have assigned a buy rating to the company. The stock currently has an average rating of Buy and a consensus target price of $175.19.
Shares of Aetna (AET) traded up $0.21 during mid-day trading on Wednesday, reaching $178.90. 5,898,300 shares of the company traded hands, compared to its average volume of 2,580,301. Aetna has a one year low of $116.04 and a one year high of $192.37. The stock has a market cap of $58,283.73, a P/E ratio of 17.50, a price-to-earnings-growth ratio of 1.63 and a beta of 0.61. The company has a quick ratio of 0.53, a current ratio of 0.53 and a debt-to-equity ratio of 0.52.
The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 26th. Stockholders of record on Thursday, January 11th will be paid a $0.50 dividend. This represents a $2.00 annualized dividend and a dividend yield of 1.12%. The ex-dividend date is Wednesday, January 10th. Aetna’s dividend payout ratio (DPR) is presently 37.04%.
In other news, EVP Margaret M. Mccarthy sold 10,288 shares of the stock in a transaction that occurred on Friday, September 15th. The shares were sold at an average price of $162.85, for a total value of $1,675,400.80. Following the transaction, the executive vice president now owns 33,563 shares in the company, valued at approximately $5,465,734.55. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, President Karen S. Lynch sold 15,271 shares of the stock in a transaction that occurred on Monday, September 18th. The stock was sold at an average price of $161.91, for a total transaction of $2,472,527.61. Following the completion of the transaction, the president now owns 64,261 shares in the company, valued at approximately $10,404,498.51. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Wells Fargo & Company MN raised its stake in Aetna by 4.2% during the 3rd quarter. Wells Fargo & Company MN now owns 1,365,596 shares of the company’s stock worth $217,144,000 after acquiring an additional 54,928 shares during the period. State of Tennessee Treasury Department raised its stake in Aetna by 26.3% during the 2nd quarter. State of Tennessee Treasury Department now owns 557,814 shares of the company’s stock worth $84,692,000 after acquiring an additional 116,280 shares during the period. Fayez Sarofim & Co. raised its stake in Aetna by 82.8% during the 3rd quarter. Fayez Sarofim & Co. now owns 7,427 shares of the company’s stock worth $1,181,000 after acquiring an additional 3,365 shares during the period. Banque Pictet & Cie SA bought a new stake in Aetna during the 2nd quarter worth approximately $10,567,000. Finally, Pictet & Cie Europe SA bought a new stake in Aetna during the 2nd quarter worth approximately $2,269,000. Institutional investors own 88.03% of the company’s stock.
COPYRIGHT VIOLATION WARNING: This piece of content was posted by Ticker Report and is the sole property of of Ticker Report. If you are reading this piece of content on another domain, it was copied illegally and reposted in violation of international copyright laws. The legal version of this piece of content can be accessed at https://www.tickerreport.com/banking-finance/3079908/aetnas-aet-neutral-rating-reaffirmed-at-credit-suisse-group.html.
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.